BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 34284773)

  • 21. Prognostic Relevance of the Peritoneal Surface Disease Severity Score Compared to the Peritoneal Cancer Index for Colorectal Peritoneal Carcinomatosis.
    Ng JL; Ong WS; Chia CS; Tan GH; Soo KC; Teo MC
    Int J Surg Oncol; 2016; 2016():2495131. PubMed ID: 27006828
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ovarian metastasis is associated with retroperitoneal lymph node relapses in women treated for colorectal peritoneal carcinomatosis.
    Eveno C; Goéré D; Dartigues P; Honoré C; Dumont F; Tzanis D; Benhaim L; Malka D; Elias D
    Ann Surg Oncol; 2013 Feb; 20(2):491-6. PubMed ID: 22956066
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Angiogenesis-Related Markers and Prognosis After Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Metastatic Colorectal Cancer.
    de Cuba EM; de Hingh IH; Sluiter NR; Kwakman R; Coupé VM; Beliën JA; Verwaal VJ; Meijerink WJ; Delis-van Diemen PM; Bonjer HJ; Meijer GA; Te Velde EA
    Ann Surg Oncol; 2016 May; 23(5):1601-8. PubMed ID: 26727921
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Complete cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for colorectal peritoneal metastasis in Norway: Prognostic factors and oncologic outcome in a national patient cohort.
    Frøysnes IS; Larsen SG; Spasojevic M; Dueland S; Flatmark K
    J Surg Oncol; 2016 Aug; 114(2):222-7. PubMed ID: 27173150
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Factors Prognostic for Brain Metastases from Colorectal Cancer: A Single-Center Experience in China.
    Wang D; Chen C; Ge X; Yang Q; Huang Y; Ling T; Jin T; Yu S; Wang J; Sun L
    Cancer Manag Res; 2021; 13():6767-6774. PubMed ID: 34512016
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Impact of Synchronous Versus Metachronous Onset of Colorectal Peritoneal Metastases on Survival Outcomes After Cytoreductive Surgery (CRS) with Hyperthermic Intraperitoneal Chemotherapy (HIPEC): A Multicenter, Retrospective, Observational Study.
    Hentzen JEKR; Rovers KP; Kuipers H; van der Plas WY; Been LB; Hoogwater FJH; van Ginkel RJ; Hemmer PHJ; van Dam GM; de Hingh IHJT; Kruijff S
    Ann Surg Oncol; 2019 Jul; 26(7):2210-2221. PubMed ID: 30877495
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Predictors of progression in high-grade appendiceal or colorectal peritoneal carcinomatosis after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy.
    Baumgartner JM; Tobin L; Heavey SF; Kelly KJ; Roeland EJ; Lowy AM
    Ann Surg Oncol; 2015 May; 22(5):1716-21. PubMed ID: 25145504
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in Asian patients: 100 consecutive patients in a single institution.
    Teo MC; Tan GH; Tham CK; Lim C; Soo KC
    Ann Surg Oncol; 2013 Sep; 20(9):2968-74. PubMed ID: 23504144
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinicopathologic Characteristics and Impact of Oophorectomy for Ovarian Metastases from Colorectal Cancer.
    Ursem C; Zhou M; Paciorek A; Atreya CE; Ko AH; Venook A; Zhang L; Van Loon K
    Oncologist; 2020 Jul; 25(7):564-571. PubMed ID: 32031306
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Preoperative platelet-lymphocyte ratio is an independent prognostic marker and superior to carcinoembryonic antigen in colorectal peritoneal carcinomatosis patients undergoing cytoreductive surgery and hyperthermic intraperitoneal chemotherapy.
    Bong TSH; Tan GHC; Chia C; Soo KC; Teo MCC
    Int J Clin Oncol; 2017 Jun; 22(3):511-518. PubMed ID: 28138878
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Thirty-three long-term survivors after cytoreductive surgery in patients with peritoneal metastases from colorectal cancer: a retrospective descriptive study.
    Kamada Y; Hida K; Ishibashi H; Sako S; Mizumoto A; Ichinose M; Padmanabhan N; Yoshida S; Yonemura Y
    World J Surg Oncol; 2021 Jan; 19(1):31. PubMed ID: 33509224
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Retrospective Analyses of Complete Resection Combined with Systemic Chemotherapy and Targeted Therapy for Patients with Ovarian Metastases from Colorectal Cancer.
    Tong G; Luo Q; Pang X; Chen B; Lv G; Li X; Wang S
    Cancer Biother Radiopharm; 2022 Sep; 37(7):553-559. PubMed ID: 33764806
    [No Abstract]   [Full Text] [Related]  

  • 33. Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC) for colorectal and appendiceal peritoneal metastases - The Hong Kong experience and literature review.
    Chow FC; Yip J; Foo DC; Wei R; Choi HK; Ng KK; Lo OS
    Asian J Surg; 2021 Jan; 44(1):221-228. PubMed ID: 32605790
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Predictive and prognostic survival factors in peritoneal carcinomatosis from appendiceal cancer after cytoreductive surgery with hyperthermic intraperitoneal chemotherapy.
    Jimenez W; Sardi A; Nieroda C; Sittig M; Milovanov V; Nunez M; Aydin N; Gushchin V
    Ann Surg Oncol; 2014 Dec; 21(13):4218-25. PubMed ID: 24986239
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Treatment of ovarian metastases of colorectal and appendiceal carcinoma in the era of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy.
    Kuijpers AM; Mehta AM; Aalbers AG; van Driel WJ; Boot H; Verwaal VJ
    Eur J Surg Oncol; 2014 Aug; 40(8):937-42. PubMed ID: 24630923
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prognostic scores for colorectal cancer with peritoneal metastases treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy.
    Enblad M; Ghanipour L; Cashin PH
    Int J Hyperthermia; 2018 Dec; 34(8):1390-1395. PubMed ID: 29695209
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prognostic significance of doubling time in patients undergoing radical surgery for metachronous peritoneal metastases of colorectal cancer.
    Miyake H; Murono K; Nagata H; Nozawa H; Kawai K; Hata K; Tanaka T; Nishikawa T; Shuno Y; Sasaki K; Ishihara S
    Int J Colorectal Dis; 2019 May; 34(5):801-809. PubMed ID: 30739186
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Development of a Prognostic Nomogram for Patients with Peritoneally Metastasized Colorectal Cancer Treated with Cytoreductive Surgery and HIPEC.
    Simkens GA; van Oudheusden TR; Nieboer D; Steyerberg EW; Rutten HJ; Luyer MD; Nienhuijs SW; de Hingh IH
    Ann Surg Oncol; 2016 Dec; 23(13):4214-4221. PubMed ID: 27027308
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prior Surgical Score: An Analysis of the Prognostic Significance of an Initial Nondefinitive Surgical Intervention in Patients With Peritoneal Carcinomatosis of a Colorectal Origin Undergoing Cytoreductive Surgery and Perioperative Intraperitoneal Chemotherapy.
    Paul BK; Ihemelandu C; Sugarbaker PH
    Dis Colon Rectum; 2018 Mar; 61(3):347-354. PubMed ID: 29420428
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Long-Term Outcomes After R0 Resection of Synchronous Peritoneal Metastasis from Colorectal Cancer Without Cytoreductive Surgery or Hyperthermic Intraperitoneal Chemotherapy.
    Shida D; Tsukamoto S; Ochiai H; Kanemitsu Y
    Ann Surg Oncol; 2018 Jan; 25(1):173-178. PubMed ID: 29063295
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.